Nel ASA's Electrolyzer Breakout Collides with a 73% Order Plunge as Stock Tumbles 24% in a Week

Investors punish Nel ASA as innovation fails to translate into orders; shares hit €0.26 amid collapsing backlog and analyst skepticism.

Investors are punishing Nel ASA for a widening gap between technological promise and commercial reality. The Norwegian hydrogen-equipment maker saw its shares shed 24.43% over seven trading days, closing Friday at €0.26 — a single-day loss of 10.64%. The rout comes without any fresh corporate announcement, the last mandatory disclosure dating back to the 6 May launch of a new pressurised alkaline electrolyser platform.

The market is now demanding evidence that product innovation translates into contracts. Nel's first-quarter results, published on 22 April, showed revenue of 148 million Norwegian kroner, down 5% year-on-year. The EBITDA loss narrowed by 15 million kroner to minus 100 million, but order intake collapsed by 73% to 85 million kroner. The total order backlog fell to 1.113 billion kroner, 24% below the level at the end of Q1 2025 — a cushion management itself acknowledges is insufficient to keep production lines busy through 2027.

Against this bleak backdrop, Nel had earlier in the year unveiled a partnership with South Korea's Samsung E&A, offering comprehensive guarantees on jointly deployed electrolyser units — a move aimed at easing project-financing hurdles. The new electrolyser platform, touted as a major cost-reduction breakthrough, sparked a brief rally that pushed the stock to a 52-week high of €0.37 in late May. That optimism has evaporated. The shares now stand 27.63% below that peak.

Analyst sentiment remains deeply sceptical. Of 13 analysts covering the stock, none rate it a buy. Seven recommend selling, while Berenberg has a "hold" rating with a price target of 2.30 kroner. The company has responded with aggressive cost-cutting, slashing its workforce by a quarter to roughly 300 employees, though it has warned that the downsizing may create bottlenecks in project execution. A small bright spot is a new order worth 70 million kroner secured in the second quarter.

Technically, the stock closed exactly on its 50-day moving average of €0.26. The 100-day line sits at €0.22 and the 200-day at €0.21, leaving a 25% buffer that suggests the broader recovery from the start of the year — a 37.98% gain — is dented but not destroyed. The RSI of 41.7 indicates no oversold condition yet, while the annualised 30-day volatility of 102.87% underscores the violent swings.

All eyes now turn to 15 July, when Nel is scheduled to release its first-half results. By then, the company must show fresh order intake that validates the Samsung alliance and the new platform's commercial traction. Without it, the hydrogen narrative risks becoming a story of innovation without revenue.